|Skin cancer probe|
Work is being done on a simple compact laser probe that can distinguish between harmless moles and cancerous ones in a matter of seconds. Daniel Louie, a PhD student, constructed the device as part of his studies in biomedical engineering at the University of British Columbia. The probe works on the principle that light waves change as they pass through objects. Researchers aimed a laser into 69 lesions from 47 volunteer patients at the Vancouver General Hospital Skin Care Centre and studied the changes that occurred to this light beam. Because cancer cells are denser, larger, and more irregularly shaped than normal cells, they caused distinctive scattering in the light waves as they passed through. Researchers were able to invent a novel way to interpret the patterns instantaneously. This optical probe can extract measurements without needing expensive lenses or cameras, and it can provide a more easily interpreted numerical result like those of a thermometer. Although the components of the probe cost only a few hundred dollars, it is not envisioned to be a consumer product. Tim Lee, an associate professor of skin science and dermatology at UBC and a senior scientist at both BC Cancer and the Vancouver Coastal Health Research Institute, supervised the work. He believes the device would be a good future addition to standard cancer screening methods, but not a replacement.
This is a joint project between UBC, BC Cancer, and the Vancouver Coastal Health Research Institute. Researchers hope to eventually achieve Health Canada certification and approval before being able to offer this testing through health professionals. This will require further refinement of the technology and additional clinical testing in more patients.
Study authors are Daniel C. Louie, Jamie Phillips, Lioudmila Tchvialeva, Sunil Kalia, Harvey Lui, Wei Wang, and Tim K. Lee. The article describing the study, “Degree of optical polarization as a tool for detecting melanoma: Proof of principle,” is in the Journal of Biomedical Optics. It is available online at https://doi.org/10.1117/1.JBO.23.12.125004.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org